Glofitamab + GemOx Superior to Rituximab + GemOx for Lymphoma
WEDNESDAY, June 26, 2024 (HealthDay News) — Glofitamab (Glofit) plus gemcitabine and...
Read More
Pharmacy
Histologic Response Up With Benralizumab for Eosinophilic Esophagitis
WEDNESDAY, June 26, 2024 (HealthDay News) — Benralizumab yields a greater histologic...
Read More
Atogepant Efficacious for Patients With Chronic Migraine
WEDNESDAY, June 26, 2024 (HealthDay News) — For patients with chronic migraine (CM), with...
Read More
ADHD Meds May Improve Opioid Use Disorder Outcomes in Pregnant Women
Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a...
Read More
SNP rs13194504 AA Genotype Linked to Severity of Tardive Dyskinesia
TUESDAY, June 25, 2024 (HealthDay News) — For patients with schizophrenia, the...
Read More
Semaglutide Cuts Incidence, Recurrence of Alcohol Use Disorder
TUESDAY, June 25, 2024 (HealthDay News) — Semaglutide may cut incidence and recurrence of...
Read More
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic Pruritus
TUESDAY, June 25, 2024 (HealthDay News) — For patients with prurigo nodularis (PN) and...
Read More
U.S. Supreme Court Agrees to Hear Case on Medical Care for Transgender Youth
MONDAY, June 24, 2024 (HealthDay News) — The U.S. Supreme Court announced Monday that it...
Read More
FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy
MONDAY, June 24, 2024 (HealthDay News) — The U.S. Food and Drug Administration has expanded...
Read More
Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017
MONDAY, June 24, 2024 (HealthDay News) — Medically advised aspirin use was lower in 2021...
Read More
Factors Influencing Post-Operative Opioid Requirements for Tibial Fractures
The following is a summary of “What influences post-operative opioid requirements for tibial...
Read More
About One-Third of Mental Health Facilities Offer Meds for Opioid Addiction
THURSDAY, June 20, 2024 (HealthDay News) — About one-third of community outpatient mental...
Read More
ViPOR Results in Durable Remission in Specific Subtypes of Lymphoma
THURSDAY, June 20, 2024 (HealthDay News) — For patients with specific subtypes of relapsed...
Read More
FDA Approves Augtyro for NTRK-Positive Advanced Solid Tumors
THURSDAY, June 20, 2024 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Reteplase Noninferior to Alteplase for Patients With Ischemic Stroke Within 4.5 Hours of Symptom Onset
Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after...
Read More
Varenicline, Nicotine-Containing E-Cigarettes Help in Quitting Smoking
WEDNESDAY, June 19, 2024 (HealthDay News) — Varenicline and nicotine-containing electronic...
Read More
Low Dose Direct Oral Anticoagulants in Patients With Atrial Fibrillation Tied to Higher Bleeding Incidence vs Standard Doses
Patients with atrial fibrillation (AF) on low doses of direct oral anticoagulants (DOACs) have...
Read More
α-1 Adrenergic Receptor Antagonists Lower Risk of Dementia With Lewy Bodies in Men
Men taking α-1 adrenergic receptor antagonists terazosin, doxazosin, and alfuzosin (Tz/Dz/Az) seem...
Read More
Continuing Metformin and Adding Insulin for T2D in Pregnancy Does Not Alter Risk for Nonlive Birth or Live Birth With Congenital Malformations
Continuing metformin and adding insulin in early pregnancy does not significantly alter the risk...
Read More
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
TUESDAY, June 18, 2024 (HealthDay News) — Lebrikizumab is associated with sustained effects...
Read More